[New post] Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial.

zedie posted: " Importance: Ovarian cancer has the highest mortality rate among gynecologic malignant tumors. Data are lacking on the survival benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in women with ovarian cancer who underwent primary or interval cyt" Respond to this post by replying above this line New post on SOMEONE SOMEWHERE Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial.  by zedie Importance: Ovarian cancer has the highest mortality rate among gynecologic malignant tumors. Data are lacking on the survival benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in women with ovarian cancer who underwent primary or interval cytoreductive surgery. Objective: To assess the clinical benefit of HIPEC after primary or interval maximal cytoreductive surgery in women with stage […] Read more of this post zedie | March 28, 2022 at 11:56 pm | Tags: Hyperthermic Intraperitoneal Chemotherapy | Categories: ONCOLOGY | URL: https://wp.me/pW0bq-z06 Comment    See all comments    Like Unsubscribe to no longer receive posts from SOMEONE SOMEWHERE. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: https://zedie.wordpress.com/2022/03/28/survival-after-hyperthermic-intraperitoneal-chemotherapy-and-primary-or-interval-cytoreductive-surgery-in-ovarian-cancer-a-randomized-clinical-trial/ Thanks for flying with WordPress.com